Resistant Hypertension in Chronic Kidney Disease
292 control. However, when thiazides and loop diuretics are used together, the incidence of adverse effects is higher and requir ...
293 severe bradycardia, particularly in patients with advanced CKD and if drugs like atenolol and bisoprolol (which accumulate i ...
294 Mineralocorticoid Receptor Antagonists Aldosterone may mediate CKD progression, independently of its BP-increasing effect. A ...
295 chosen, since BBs vary widely in their pharmacological profile [ 24 ]. A recent sys- tematic review and meta-analysis [ 46 ] ...
296 a first-dose hypotensive reaction. They are useful in CKD patients with RH, as well as in those with symptoms of prostatic h ...
297 the risk of hyperkalemia in these patients, potentially by inhibiting extrarenal potas- sium loss. Therefore, monitoring of ...
298 when compared with those treated with monotherapy. Larger studies are required to determine whether this therapeutic combina ...
299 Other Agents Alpha-blockers are seldom used in dialysis patients. However, in those requiring multiple antihypertensive agen ...
300 not ETA/ETB receptor antagonist bosentan, prevented the aggravation of hyperten- sion in renal failure rats treated with ery ...
301 counteracted with diuretics. Non-dihydropyridines should not be associated with BBs, because of risks of bradycardia and dep ...
302 Weber F, Anlauf M. Treatment resistant hypertension—investigation and conservative man- agement. Dtsch Arztebl Int. 2014;1 ...
303 Houle SK, Padwal R, Poirier L, Tsuyuki RT. The 2014 Canadian hypertension Education pro- gram (CHEP) guidelines for pharmac ...
304 Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic ren ...
305 Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients wi ...
306 Cice G, Ferrara L, D’Andrea A, D’Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabrò R. Carvedilol increases tw ...
© Springer International Publishing AG 2017 307 A. Covic et al. (eds.), Resistant Hypertension in Chronic Kidney Disease, DOI 10 ...
308 MSNA in CKD patients undergoing hemodialysis after bilateral nephrectomy did not differ from healthy subjects [ 1 ]. Hausber ...
309 Activation of the efferent fibers leads to blood pressure increase. Norepinephrine is released from nerve endings, and it ac ...
310 197 hemodialyzed patients with chronic kidney disease (with more than 6 months vintage of hemodialysis therapy), it has been ...
311 with the proximal and middle segments and the mean distance from renal artery lumen to nerve location is the lowest in the d ...
«
10
11
12
13
14
15
16
17
18
19
»
Free download pdf